Patient Satisfaction With Pharmacist-Led Chronic Disease State Management Programs

Schuessler, Tyler J.; Ruisinger, Janelle F.; Hare, Sarah E.; Prohaska, E; Melton, Brittany L.

doi:10.1177/0897190014568672

Cited by 21 publications

(13 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In developed nations, pharmacists’ role has expanded to provide a variety of services including pharmacovigilance activities [ 64 ], pharmacist prescribing [ 65 ], disease state management [ 66 ], medication reconciliation– inpatient [ 67 ] and outpatient [ 68 ], discharge management and counselling [ 69 ], home and residential aged care medication reviews [ 70 ], pharmacists in general practices [ 71 ], and pharmacists-led clinics (diabetes and cardiovascular) [ 72 ]. The provision of and outcomes from these expanded services are appreciated by physicians [ 73 , 74 ] and the public [ 75 , 76 ].…”

Section: Discussionmentioning

confidence: 99%

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

Sakeena

Bennett²,

McLachlan

2018

Antimicrob Resist Infect Control

140

101

View full text Add to dashboard Cite

BackgroundAntimicrobial resistance (AMR) is a global health challenge and developing countries are more vulnerable to the adverse health impacts of AMR. Health care workers including pharmacists can play a key role to support the appropriate use of antimicrobials in developing countries and reduce AMR.ObjectiveThe aim of this review is to investigate the role of pharmacists in the appropriate use of antibiotics and to identify how the pharmacists’ role can be enhanced to combat AMR in developing countries.MethodThe databases MEDLINE, EMBASE, Web of Science and Google Scholar were searched for articles published between 2000 and the end of August 2017 that involved studies on the role of pharmacists in developing countries, the expanded services of pharmacists in patient care in developed countries and pharmacists’ contributions in antimicrobial use in both developed and developing nations.Key findingsIn developing countries pharmacists role in patient care are relatively limited. However, in developed nations, the pharmacists’ role has expanded to provide multifaceted services in patient care resulting in improved health outcomes from clinical services and reduced health care costs. Success stories of pharmacist-led programs in combating AMR demonstrates that appropriately trained pharmacists can be part of the solution to overcome the global challenge of AMR. Pharmacists can provide education to patients enabling them to use antibiotics appropriately. They can also provide guidance to their healthcare colleagues on appropriate antibiotic prescribing.ConclusionsThis review highlights that appropriately trained pharmacists integrated into the health care system can make a significant impact in minimising inappropriate antibiotic use in developing countries. Strengthening and enhancing the pharmacists’ role in developing countries has the potential to positively impact the global issue of AMR.

show abstract

Section: Discussionmentioning

confidence: 99%

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

Sakeena

Bennett²,

McLachlan

2018

Antimicrob Resist Infect Control

140

101

View full text Add to dashboard Cite

show abstract

“…58 , 59 Patient satisfaction also served as an important determinant of the viability and sustainability of healthcare services, effective use of healthcare resources, likelihood of continuously using healthcare services, adherence to treatment, and resulting in better health outcomes. 60 , 61 However, reports about humanistic outcomes associated with pharmacists’ intervention in COPD management remained scarce. The value of pharmacists’ intervention should also be measured in economic terms, whether they be direct, indirect, or intangible costs.…”

Section: Discussionmentioning

confidence: 99%

<p>Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model</p>

Yao

Ung

et al. 2020

COPD

View full text Add to dashboard Cite

This study aimed 1) to identify and analyse the professional services provided by community pharmacists for chronic obstructive pulmonary disease (COPD) management; and 2) to develop a logic model for community pharmacy practice for COPD management. Methods: A systematic review with a logic model was applied. English-language databases (PubMed, Web of Science, Embase, and Scopus) and a Chinese database (CNKI) were searched for articles published between January 2009 and June 2019. Studies concerning pharmacists and COPD were identified to screen for studies that focused on professional services provided at a community pharmacy level. Evidence on economic, clinical, and humanistic outcomes of interventions was summarized. Results: Twenty-five articles were included in this study. Four categories of COPD-related interventions by community pharmacists were identified: 1) primary prevention; 2) early detection; 3) therapy management; and 4) long-term health management. The most common outputs examined were improvement in inhaler technique, medication adherence, and rate of smoking cessation. The clinical (improved quality of life, reduced frequency and severity of symptoms and exacerbation), humanistic (patient satisfaction), and economic (overall healthcare costs) outcomes were tested for some interventions through clinical studies. Contextual factors concerning pharmacists, healthcare providers, patients, facilities, clinic context, and socioeconomic aspects were also identified. Conclusion: Studies in the literature have proposed and examined different components of professional services provided by community pharmacists for COPD management. However, relationships among outcomes, comprehensive professional services of community pharmacists, and contextual factors have not been systematically tested. More well-designed, rigorous studies with more sensitive and specific outcomes measures need to be conducted to assess the effect of community pharmacy practice for COPD management.

show abstract

“…7 Pharmacists, as widely accessible health care providers, are well positioned to support employee health and well-being initiatives. 8…”

Section: Introductionmentioning

confidence: 99%

“…7 Pharmacists, as widely accessible health care providers, are well positioned to support employee health and well-being initiatives. 8 The University of British Columbia (UBC) employs more than 16 400 faculty and staff across 2 campuses and several satellite sites. 9 UBC has a well-established workplace health and well-being program.…”

Section: Introductionmentioning

confidence: 99%

Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)

et al. 2019

View full text Add to dashboard Cite

Background: Cardiovascular (CV) disease is a leading cause of death despite being largely preventable. Employers increasingly offer preventive health programs in the workplace, and pharmacists are well suited to provide these programs. Objective: To evaluate the impact of a pharmacist-led service on CV risk in University of British Columbia (UBC) employees. Methods: This was a prospective observational pre-and-post design study, with participants as their own controls. Employees >18 years of age in the UBC health plan with a Framingham Risk Score (FRS) ≥10% or ≥1 medication-modifiable CV risk factor were included. Participants received a baseline assessment, individualized consultation for 12 months, and a final assessment by a pharmacist at the UBC Pharmacists Clinic. The primary end point was FRS reduction. Results: Baseline assessment of 512 participants between September 2015 and October 2016 yielded 207 (40%) participants, of whom 178 (86%) completed the 12-month intervention. Participants were 54% female and 55% Caucasian, with an average age of 51 (SD = 9.1) years. FRS at baseline was <10 in 45.8%, 10 to 19.9 in 37.9%, and ≥20 in 16.4% of participants. Over 12 months, significant reductions in average FRS (from 11.7 [SD = 7.7] to 10.7 [SD = 7.3]; P = 0.0017) and other parameters were observed. Significant improvements in quality of life (EQ5D change of 0.031 [95% CI = 0.001, 0.062] P = 0.023) and medication adherence (MMAS-8 change of 0.42 [ P = 0.019]) were also noted. Conclusions and Relevance: UBC employees had improvements in health markers, self-reported quality of life, and medication adherence after receiving a 12-month pharmacist-led intervention. Pharmacists are encouraged to provide CV risk reduction services in workplaces.

show abstract

Patient Satisfaction With Pharmacist-Led Chronic Disease State Management Programs

Abstract: Positive patient responses to the program support use of pharmacist-led DSM programs.

Cited by 21 publications

References 21 publications

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

<p>Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model</p>

Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)

Contact Info

Product

Resources

About